Advertisement

Science China Life Sciences

, Volume 61, Issue 8, pp 924–933 | Cite as

Combined prednisone and levothyroxine improve treatment of severe thrombocytopenia in hepatitis B with compensatory cirrhosis accompanied by subclinical and overt hypothyroidism

  • Jing Xue
  • Ru Feng
  • Haixia Fu
  • Qian Jiang
  • Hao Jiang
  • Jing Lu
  • Hui Liu
  • Jingwen Wang
  • Ting Niu
  • Xin Wang
  • Yandi Xie
  • Hao Wang
  • Lanping Xu
  • Kaiyan Liu
  • Xiaojun Huang
  • Xiaohui Zhang
Research Paper
  • 21 Downloads

Abstract

The aim of the present study was to investigate the relationship between hypothyroidism and thrombocytopenia in hepatitis B-related compensatory liver cirrhosis and to determine whether treatment with levothyroxine and prednisone is superior in a multicenter, open-label, observational study in China. In total, 125 consecutive hepatitis B-related compensated liver cirrhosis patients with severe thrombocytopenia accompanied by hypothyroidism were included. The patients were divided into four groups according to treatment strategy: a control group (n=29), a prednisone group (n=25), a levothyroxine group (n=32) and a prednisone plus levothyroxine group (n=39). Severe thrombocytopenia was more prevalent in hepatitis B-associated compensatory liver cirrhosis patients with hypothyroidism than in euthyroid patients (29.6% vs. 14.7%, P<0.05). Combination treatment with prednisone and levothyroxine decreased the risk of bleeding and improved platelet recovery compared to control treatment and treatment with either prednisone or levothyroxine alone. The platelet count before therapy, serum thyroid stimulating hormone and combination treatment with prednisone and levothyroxine were associated with bleeding events. Therefore, the present study suggests that hypothyroidism is associated with severe thrombocytopenia in hepatitis B-associated compensatory liver cirrhosis. Treatment with prednisone plus levothyroxine may present a novel approach in these patients.

Keywords

hepatitis B cirrhosis thrombocytopenia hypothyroidism treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

The authors thank their nurses’ team and technicians in executing this study. We also thank Yang Wang from State Key Laboratory of Translational Cardiovascular Medicine, Fuwai Hospital & Cardiovascular Institute for statistic analysis. This work was supported by National Natural Science Foundation of China (81470343, 81670116), National Natural Science Foundation for Young Scholars of China (81600132), Key Program of National Natural Science Foundation of China (81730004), Beijing Natural Science Foundation (7171013), Beijing Municipal Science and Technology Commission (Z171100001017084), the National Key Research and Development Program of China (2017YFA0105503) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001).

References

  1. Antonelli, A., Ferri, C., Pampana, A., Fallahi, P., Nesti, C., Pasquini, M., Marchi, S., and Ferrannini, E. (2004). Thyroid disorders in chronic hepatitis C. Am J Med 117, 10–13.CrossRefPubMedGoogle Scholar
  2. Atalay, R., Ersoy, R., Demirezer, A.B., Akın, F.E., Polat, S.B., Cakir, B., and Ersoy, O. (2015). Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver. Endocrine 48, 942–948.CrossRefPubMedGoogle Scholar
  3. Baskin, H.J., Cobin, R.H., Duick, D.S., Gharib, H., Guttler, R.B., Kaplan, M.M., Segal, R.L., Garber, J.R., Hamilton Jr., C.R., Handelsman, Y., Hellman, R., Kukora, J.S., Levy, P., Palumbo, P.J., Petak, S.M., Rettinger, H.I., Rodbard, H.W., Service, F.J., Shankar, T.P., Stoffer, S.S., Tourtelot, J.B. (2002). American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8, 457–469.CrossRefGoogle Scholar
  4. Biró, E., Szekanecz, Z., Czirják, L., Dankó, K., Kiss, E., Szabó, N.A., Szucs, G., Zeher, M., Bodolay, E., Szegedi, G., Bakó, G. (2006). Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25, 240–245.CrossRefPubMedGoogle Scholar
  5. Blackard, J.T., Kong, L., Huber, A.K., and Tomer, Y. (2013). Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid 23, 863–870.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bowles, K.M., Turner, G.E., and Wimperis, J.Z. (2004). Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism. J Clin Pathol 57, 995–996.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Brabant, A., Brabant, G., Schuermeyer, T., Ranft, U., Schmidt, F.W., Hesch, R.D., and von zur Muhlen, A. (1989). The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol (Copenh) 121, 95–100.Google Scholar
  8. Cable, E.E., Finn, P.D., Stebbins, J.W., Hou, J., Ito, B.R., van Poelje, P.D., Linemeyer, D.L., and Erion, M.D. (2009). Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 49, 407–417.CrossRefPubMedGoogle Scholar
  9. Carulli, L., Ballestri, S., Lonardo, A., Lami, F., Violi, E., Losi, L., Bonilauri, L., Verrone, A.M., Odoardi, M.R., Scaglioni, F., Bertolotti, M., and Loria, P. (2013). Is nonalcoholic steatohepatitis associated with a highthough- normal thyroid stimulating hormone level and lower cholesterol levels? Intern Emerg Med 8, 297–305.CrossRefPubMedGoogle Scholar
  10. Cheung, E., and Liebman, H.A. (2009). Thyroid disease in patients with immune thrombocytopenia. Hematol Oncol Clin North Am 23, 1251–1260.CrossRefPubMedGoogle Scholar
  11. Committee, W.G.A.b.t.G.R. (2015). Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. (Geneva: World Health Organization).Google Scholar
  12. Cooper, D.S., and Biondi, B. (2012). Subclinical thyroid disease. Lancet 379, 1142–1154.CrossRefPubMedGoogle Scholar
  13. Ding, W.J., Wang, M.M., Wang, G.S., Shen, F., Qin, J.J., and Fan, J.G. (2015). Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects. J Gastroenterol Hepatol 30, 1753–1758.CrossRefPubMedGoogle Scholar
  14. Garber, J.R., Cobin, R.H., Gharib, H., Hennessey, J.V., Klein, I., Mechanick, J.I., Pessah-Pollack, R., Singer, P.A., Woeber, K.A., Woeber, K.A. (2012). Clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association. Thyroid 22, 1200–1235.CrossRefPubMedGoogle Scholar
  15. Haugen, B.R. (2009). Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23, 793–800.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Hou, J.L. (2015). The guideline of prevention and treatment for chronic hepatitis B: a 2015 update (in Chinese). Chin J Hepatol 23, 888–905.Google Scholar
  17. Ioachimescu, A.G., Makdissi, A., Lichtin, A., and Zimmerman, R.S. (2007). Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study. Thyroid 17, 1137–1142.CrossRefPubMedGoogle Scholar
  18. Kang, M.Y., Hahm, J.R., Jung, T.S., Lee, G.W., Kim, D.R., and Park, M.H. (2006). A 20-year-old woman with Hashimoto’s thyroiditis and Evans’ syndrome. Yonsei Med J 47, 432–436.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Kim, S.U., Lee, J.H., Kim, D.Y., Ahn, S.H., Jung, K.S., Choi, E.H., Park, Y. N., Han, K.H., Chon, C.Y., Park, J.Y. (2012). Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS ONE 7, e36676.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Mansour-Ghanaei, F., Mehrdad, M., Mortazavi, S., Joukar, F., Khak, M., and Atrkar-Roushan, Z. (2012). Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Ann Hepatol 11, 667–671.PubMedGoogle Scholar
  21. Napolitano, M., Malato, A., Raffaele, F., Palazzolo, M., Lo Iacono, G., Pinna, R., Geraci, G., Modica, G., Saccullo, G., Siragusa, S., and Cajozzo, M. (2013). Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia. Blood Transfus 11, 506–509.PubMedPubMedCentralGoogle Scholar
  22. Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., Crowther, M. A., and Crowther, M.A. (2011). The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117, 4190–4207.CrossRefPubMedGoogle Scholar
  23. Page, L.K., Psaila, B., Provan, D., Michael Hamilton, J., Jenkins, J.M., Elish, A.S., Lesser, M.L., and Bussel, J.B. (2007). The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 138, 245–248.CrossRefPubMedGoogle Scholar
  24. Perra, A., Simbula, G., Simbula, M., Pibiri, M., Kowalik, M.A., Sulas, P., Cocco, M.T., Ledda-Columbano, G.M., and Columbano, A. (2008). Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J 22, 2981–2989.CrossRefPubMedGoogle Scholar
  25. Pradella, P., Bonetto, S., Turchetto, S., Uxa, L., Comar, C., Zorat, F., De Angelis, V., and Pozzato, G. (2011). Platelet production and destruction in liver cirrhosis. J Hepatol 54, 894–900.CrossRefPubMedGoogle Scholar
  26. Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kühne, T., Ruggeri, M., George, J.N. (2009). Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113, 2386–2393.CrossRefPubMedGoogle Scholar
  27. Rugge, B., Balshem, H., Sehgal, R., Relevo, R., Gorman, P., and Helfand, M. (2011). AHRQ Comparative Effectiveness Reviews. In Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (Rockville (MD), Agency for Healthcare Research and Quality (US)).Google Scholar
  28. Sarin, S.K., Kumar, M., Lau, G.K., Abbas, Z., Chan, H.L.Y., Chen, C.J., Chen, D.S., Chen, H.L., Chen, P.J., Chien, R.N., Dokmeci, A.K., Gane, E., Hou, J.L., Jafri, W., Jia, J., Kim, J.H., Lai, C.L., Lee, H.C., Lim, S. G., Liu, C.J., Locarnini, S., Al Mahtab, M., Mohamed, R., Omata, M., Park, J., Piratvisuth, T., Sharma, B.C., Sollano, J., Wang, F.S., Wei, L., Yuen, M.F., Zheng, S.S., Kao, J.H. (2016). Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 10, 1–98.CrossRefPubMedGoogle Scholar
  29. Sarkar, S., Mondal, R., Nandi, M., and Ghosh, J. (2013). Immune thrombocytopenic purpura in a child with thyroid hormone resistance—a rare presentation. J Pediatr Endocrinol Metab 26, 125–127.PubMedGoogle Scholar
  30. Shen, Y., Wang, X.L., Xie, J.P., Shao, J.G., Lu, Y.H., Zhang, S., and Qin, G. (2016). Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis. J Gastrointestin Liver Dis 25, 227–234.PubMedGoogle Scholar
  31. Tahir, H., Sheraz, F., Sagi, J., and Daruwalla, V. (2016). Immune thrombocytopenia (ITP) secondary to subclinical hashimoto’s thyroiditis: role of levothyroxine in improving the clinical outcome of ITP. J Investig Med High Impact Case Rep 4, 2324709616647085.Google Scholar
  32. Teixeira, P.F.S., Reuters, V.S., Ferreira, M.M., Almeida, C.P., Reis, F.A.A., Melo, B.A., Buescu, A., Costa, A.J.L., and Vaisman, M. (2008). Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res 40, 50–55.CrossRefPubMedGoogle Scholar
  33. Wong, G.L.H., Chan, H.L.Y., Mak, C.W.H., Lee, S.K.Y., Ip, Z.M.Y., Lam, A.T.H., Iu, H.W.H., Leung, J.M.S., Lai, J.W.Y., Lo, A.O.S., Chan, H.Y., Wong, V.W.S. (2013). Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis. Hepatology 58, 1537–1547.CrossRefPubMedGoogle Scholar
  34. Wu, Y., You, S., Zang, H., Liu, H., Mao, Y., Mao, P., Zhu, B., Xu, J., Xie, G., Guo, J., Li, D., Xin, S., and Wan, Z. (2015). Usefulness of serum thyroid-stimulation hormone (TSH) as a prognostic indicator for acuteon- chronic liver failure. Ann Hepatol 14, 218–224.PubMedGoogle Scholar
  35. Yang, R., Shan, Z., Li, Y., Fan, C., Li, C., and Teng, W. (2011). Prevalence of thyroid autoantibodies in hepatitis C and hepatits B infection in China. Intern Med 50, 811–815.CrossRefPubMedGoogle Scholar
  36. Zhang, X.H., Feng, R., Xu, L.P., Jiang, Q., Jiang, H., Fu, H.X., Liu, H., Niu, T., Wang, X., Hu, J.D., Jiang, M., Wang, Z., Wang, J.W., Ma, H., Xie, Y. D., Zhu, X.L., Wang, H., Wei, L., Huang, X.J. (2015). Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: a multicenter, observational study. Platelets 26, 672–679.CrossRefPubMedGoogle Scholar
  37. Zhang, X.H., He, Y., Feng, R., Xu, L.P., Jiang, Q., Jiang, H., Lu, J., Fu, H. X., Liu, H., Wang, J.W., Wang, Q.M., Feng, F.E., Zhu, X.L., Xu, L.L., Xie, Y.D., Ma, H., Wang, H., Liu, K.Y., Huang, X.J. (2016). Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: a multicenter, observational study. Platelets 27, 223–229.CrossRefPubMedGoogle Scholar

Copyright information

© Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Jing Xue
    • 1
  • Ru Feng
    • 2
  • Haixia Fu
    • 1
  • Qian Jiang
    • 1
  • Hao Jiang
    • 1
  • Jing Lu
    • 1
  • Hui Liu
    • 2
  • Jingwen Wang
    • 3
  • Ting Niu
    • 4
  • Xin Wang
    • 5
  • Yandi Xie
    • 6
  • Hao Wang
    • 6
  • Lanping Xu
    • 1
  • Kaiyan Liu
    • 1
  • Xiaojun Huang
    • 1
  • Xiaohui Zhang
    • 1
  1. 1.Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of HematologyPeking UniversityBeijingChina
  2. 2.Departments of Hematology, Beijing HospitalNational Center of GerontologyBeijingChina
  3. 3.Department of HematologyBeijing Tongren HospitalBeijingChina
  4. 4.Department of HematologySichuan University West China Medical CenterChengduChina
  5. 5.Department of HematologyShandong Provincial HospitalQingdaoChina
  6. 6.Peking University, People’s HospitalInstitute of Hepatic DiseasesBeijingChina

Personalised recommendations